検索結果 - Christopher J. Lees

  • 検索結果 1 - 10 結果 / 10
結果の絞り込み
  1. 1
    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality

    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality 著者: Patricia A. Taylor, Christopher J. Lees, Bruce R. Blazar

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions

    Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions 著者: Patricia A. Taylor, Christopher J. Lees, Herman Waldmann, Randolph J. Noelle, Bruce R. Blazar

    出版事項 2001
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    B7 Expression on T Cells Down-Regulates Immune Responses through CTLA-4 Ligation via R-T Interactions

    B7 Expression on T Cells Down-Regulates Immune Responses through CTLA-4 Ligation via R-T Interactions 著者: Patricia A. Taylor, Christopher J. Lees, Sylvie Fournier, James P. Allison, Arlene H. Sharpe, Bruce R. Blazar

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions

    Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions 著者: Patricia A. Taylor, Christopher J. Lees, Jessica Wilson, Michael Ehrhardt, Matthew T. Campbell, Randolph J. Noelle, Bruce R. Blazar

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

    Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD) 著者: Patricia A. Taylor, Michael Ehrhardt, Christopher J. Lees, Jakub Tolar, Brenda J. Weigel, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Volker Brinkmann, Bruce R. Blazar

    出版事項 2007
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I

    Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I 著者: Mark J. Osborn, Ron McElmurry, Christopher J. Lees, Anthony P. DeFeo, Zhi-Ying Chen, Mark A. Kay, Luigi Naldini, Gordon J. Freeman, Jakub Tolar, Bruce R. Blazar

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

    TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection 著者: Patricia A. Taylor, Michael Ehrhardt, Christopher J. Lees, Angela Panoskaltsis‐Mortari, Arthur Μ. Krieg, Arlene H. Sharpe, William J. Murphy, Jonathan S. Serody, Hiroaki Hemmi, Shizuo Akira, Robert B. Levy, Bruce R. Blazar

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells

    Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells 著者: Beau R. Webber, Kyle T O'Connor, Ron McElmurry, Elise N Durgin, Cindy Eide, Christopher J. Lees, Megan Riddle, Wendy Mathews, Natasha Y. Frank, Mark A. Kluth, Christoph Ganss, Branden S. Moriarity, Markus H. Frank, Mark J. Osborn, Jakub Tolar

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa

    CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa 著者: Beau R. Webber, Mark J. Osborn, Amber McElroy, Kirk Twaroski, Cara-Lin Lonetree, Anthony P. DeFeo, Lily Xia, Cindy Eide, Christopher J. Lees, Ron McElmurry, Megan Riddle, Chong Jai Kim, Dharmeshkumar Patel, Bruce R. Blazar, Jakub Tolar

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Sleeping Beauty Transposon‐mediated Engineering of Human Primary T Cells for Therapy of CD19+ Lymphoid Malignancies

    Sleeping Beauty Transposon‐mediated Engineering of Human Primary T Cells for Therapy of CD19+ Lymphoid Malignancies 著者: Xin Huang, Hongfeng Guo, Johnthomas Kang, Suet Choi, Tom C. Zhou, Syam Tammana, Christopher J. Lees, Zhong-ze Li, Michael C. Milone, Bruce L. Levine, Jakub Tolar, Carl H. June, R. Scott McIvor, John E. Wagner, Bruce R. Blazar, Xianzheng Zhou

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: